Clinical Trial Update: A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 trial of AURN001 in corneal edema due to corneal endothelial dysfunction have been completed with results posted. The study, sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Edema
• Corneal Endothelial Dysfunction

Drugs mentioned

• AURN001

Snippet

Sponsor: Aurion Biotech | Conditions: Corneal Edema, Corneal Endothelial Dysfunction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-12-17